NO983283D0 - Hydrocamic acid-based collagenase inhibitors - Google Patents

Hydrocamic acid-based collagenase inhibitors

Info

Publication number: NO983283D0
Authority: NO; Norway
Prior art keywords: hydrocamic; acid; collagenase inhibitors; based collagenase; inhibitors
Prior art date: 1996-01-17

Application number

NO983283A

Other languages

Norwegian (no)

Other versions

NO983283L (en

Inventor

Stuart Bailey

Derek Richard Buckle

Andrew Faller

David Glynn Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-17

Filing date

1998-07-16

Publication date

1998-07-16

1998-07-16 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1998-07-16 Publication of NO983283D0 publication Critical patent/NO983283D0/en

1998-09-16 Publication of NO983283L publication Critical patent/NO983283L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO983283A 1996-01-17 1998-07-16 Hydrocamic acid-based collagenase inhibitors NO983283L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9601041.8A GB9601041D0 (en)	1996-01-17	1996-01-17	Novel compounds
PCT/EP1997/000196 WO1997026257A1 (en)	1996-01-17	1997-01-14	Hydroxamic acid based collagenase inhibitors

Publications (2)

Publication Number	Publication Date
NO983283D0 true NO983283D0 (en)	1998-07-16
NO983283L NO983283L (en)	1998-09-16

Family

ID=10787226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983283A NO983283L (en)	1996-01-17	1998-07-16	Hydrocamic acid-based collagenase inhibitors

Country Status (19)

Country	Link
EP (1)	EP0912545A1 (en)
JP (1)	JP2000503312A (en)
KR (1)	KR19990077325A (en)
CN (1)	CN1213368A (en)
AR (1)	AR005472A1 (en)
AU (1)	AU725056B2 (en)
BR (1)	BR9707024A (en)
CA (1)	CA2242913A1 (en)
CZ (1)	CZ222498A3 (en)
GB (1)	GB9601041D0 (en)
HU (1)	HUP9901022A3 (en)
IL (1)	IL125381A0 (en)
NO (1)	NO983283L (en)
NZ (1)	NZ326352A (en)
PL (1)	PL327820A1 (en)
TR (1)	TR199801380T2 (en)
TW (1)	TW462967B (en)
WO (1)	WO1997026257A1 (en)
ZA (1)	ZA97345B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6548084B2 (en)	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
GB9609795D0 (en) *	1996-05-10	1996-07-17	Smithkline Beecham Plc	Novel compounds
AU1960100A (en) *	1999-01-06	2000-07-24	Mcmaster University	Method of preventing immune and hypersensitivity reactions
GB9922825D0 (en) *	1999-09-25	1999-11-24	Smithkline Beecham Biolog	Medical use
WO2002006227A1 (en) *	2000-07-18	2002-01-24	Chugai Seiyaku Kabushiki Kaisha	Matrix metalloprotease inhibitors
MXPA04007311A (en) *	2002-01-28	2005-05-16	Aimsco Ltd	Treatment of ms with goat serum.
US7521563B2 (en)	2004-08-10	2009-04-21	Shizuoka Coffein Co., Ltd.	Hydroxamic acid derivative and medicine containing the same as active ingredient
KR100844277B1 (en) *	2005-04-29	2008-07-07	(주)아모레퍼시픽	A hydroxamic acid derivative and the preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4743587A (en) *	1985-09-10	1988-05-10	G. D. Searle & Co.	Hydroxamic acid based collagenase inhibitors
GB8827305D0 (en) *	1988-11-23	1988-12-29	British Bio Technology	Compounds
GB9504084D0 (en) *	1995-03-01	1995-04-19	British Biotech Pharm	Synthesis of carboxylic and hydroxamic acid derivatives

1996
- 1996-01-17 GB GBGB9601041.8A patent/GB9601041D0/en active Pending
1997
- 1997-01-14 PL PL97327820A patent/PL327820A1/en unknown
- 1997-01-14 CZ CZ982224A patent/CZ222498A3/en unknown
- 1997-01-14 EP EP97901055A patent/EP0912545A1/en not_active Withdrawn
- 1997-01-14 KR KR1019980705472A patent/KR19990077325A/en not_active Application Discontinuation
- 1997-01-14 BR BR9707024A patent/BR9707024A/en unknown
- 1997-01-14 NZ NZ326352A patent/NZ326352A/en unknown
- 1997-01-14 HU HU9901022A patent/HUP9901022A3/en unknown
- 1997-01-14 TR TR1998/01380T patent/TR199801380T2/en unknown
- 1997-01-14 IL IL12538197A patent/IL125381A0/en unknown
- 1997-01-14 CN CN97192982A patent/CN1213368A/en active Pending
- 1997-01-14 AU AU14436/97A patent/AU725056B2/en not_active Ceased
- 1997-01-14 JP JP9525693A patent/JP2000503312A/en active Pending
- 1997-01-14 WO PCT/EP1997/000196 patent/WO1997026257A1/en not_active Application Discontinuation
- 1997-01-14 CA CA002242913A patent/CA2242913A1/en not_active Abandoned
- 1997-01-15 AR ARP970100153A patent/AR005472A1/en unknown
- 1997-01-16 ZA ZA97345A patent/ZA97345B/en unknown
- 1997-01-30 TW TW086101017A patent/TW462967B/en active
1998
- 1998-07-16 NO NO983283A patent/NO983283L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1213368A (en)	1999-04-07
AU725056B2 (en)	2000-10-05
NZ326352A (en)	2000-03-27
AR005472A1 (en)	1999-06-23
CA2242913A1 (en)	1997-07-24
HUP9901022A3 (en)	2001-11-28
KR19990077325A (en)	1999-10-25
JP2000503312A (en)	2000-03-21
HUP9901022A2 (en)	1999-07-28
AU1443697A (en)	1997-08-11
GB9601041D0 (en)	1996-03-20
ZA97345B (en)	1998-07-16
BR9707024A (en)	1999-07-20
PL327820A1 (en)	1999-01-04
WO1997026257A1 (en)	1997-07-24
CZ222498A3 (en)	1999-03-17
TR199801380T2 (en)	1998-10-21
TW462967B (en)	2001-11-11
NO983283L (en)	1998-09-16
EP0912545A1 (en)	1999-05-06
IL125381A0 (en)	1999-03-12

Publication	Publication Date	Title
ID19198A (en)	1998-06-28	HETEROSICLIC METALOPROTEASE INHIBITORS
ID18416A (en)	1998-04-09	DIHETEROSICLIC METALOPROTEASE INHIBITORS
NO995433D0 (en)	1999-11-05	Protease inhibitors
FI963597A0 (en)	1996-09-12	Isoprenyylitransferaasi inhibitors
NO972930D0 (en)	1997-06-23	Fibronectin-adhesion inhibitors
NO20006716D0 (en)	2000-12-29	protease inhibitors
LV12150A (en)	1998-10-20	Farnesyltransferase inhibitors
FI972160A (en)	1997-05-22	Matriisimetalloproteaasi inhibitors
PT936912E (en)	2004-06-30	CISTEIN PROTEASE INHIBITORS
DK1027332T3 (en)	2004-10-04	New lactametalloprotease inhibitors
DK0958287T3 (en)	2003-01-20	Sulfamidmetalloprotease inhibitors
NO20000464L (en)	2000-03-30	Acyclic metalloprotease inhibitors
NO996578D0 (en)	1999-12-30	Urokinase inhibitors
NO974403L (en)	1997-11-17	Reversible protease inhibitors
PT956294E (en)	2004-10-29	TROMBIN INHIBITORS
NO995434L (en)	1999-11-05	protease inhibitors
NO995435D0 (en)	1999-11-05	Protease inhibitors
NO990896D0 (en)	1999-02-25	Bidentate metalloprotease inhibitors
NO995268D0 (en)	1999-10-28	protease inhibitors
NO980643D0 (en)	1998-02-16	Propylene dopeptidase inhibitors
NO983283D0 (en)	1998-07-16	Hydrocamic acid-based collagenase inhibitors
ATE282629T1 (en)	2004-12-15	THROMBIN INHIBITORS
PT948483E (en)	2002-08-30	FARNESIL-TRANSFERASE INHIBITORS
DE69828361D1 (en)	2005-02-03	APOPTOSIS INHIBITOR
DE69720957T2 (en)	2004-01-29	ACE INHIBITORS

Legal Events

Date	Code	Title	Description
2002-10-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application